Login / Signup

Pivotal Evaluation of Novel Dedicated Venous Stent for Iliofemoral Venous Obstruction: A Prospective Cohort Study.

Xiaohui MaJue YangMinyi YinFeng LiuWeiwei WuYongjun LiXiao QinLei ZhangZhanxiang XiaoHao XuYunfeng ZhuLi-Xin WangJie ZhangLonghua FanXiangchen DaiMu YangBing ChenBin HaoShaomang LinBenlu LiaoWei Guo FuWei Guo
Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2024)
The design of venous stents for iliofemoral venous obstruction (IVO) must address engineering challenges distinct from those encountered in arterial stenting. The Grency venous stent, a nitinol self-expanding stent specifically tailored for IVO, features a composite structure designed to meet the stent requirements of various iliac vein segments. The Grency Trial is a prospective, multicenter, single-arm, open-label pivotal study aimed at evaluating the efficacy and safety of the Grency stent system. Following a 12-month follow-up period, the Grency venous stent system has demonstrated both safety and efficacy in treating iliofemoral venous outflow obstruction.
Keyphrases
  • open label
  • clinical trial
  • squamous cell carcinoma
  • study protocol
  • phase ii
  • phase iii
  • percutaneous coronary intervention
  • atrial fibrillation
  • antiplatelet therapy
  • rectal cancer